tamoxifen and tirzepatide GLP-1 Agonists Poised to Impact Breast Cancer Care | Targeted Oncology Highlighting 3 ongoing clinical trials

More on this topic Suicide risk Initial concerns about suicidal thoughts among users led to a review by the European Medicines Agency, which found no causal link

By integrating Tirzepatide with nutrition counseling, lifestyle coaching, and medical oversight, our team ensures that patients receive safe, effective, and sustainable weight loss support

doi: 10.1038/s41598-019-39060-1 94 Ortega-HernandezODShoenfeldY

Summary: New GLP-1 and related drugs are likely to become available over the next 3-5 years, and this drug class will likely be approved for additional indications

Besides the benefit in the lowering of cholesterol, GLP-1 receptor agonists also have been implicated to reduce systolic blood pressure in patients 8